BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)

Vγ9Vδ2 T cells are anti-tumor immune effectors of growing interest in cancer including Pancreatic Ductal Adenocarcinoma (PDAC), an especially aggressive cancer characterized by a hypoxic and nutrient-starved immunosuppressive microenvironment. Since Butyrophilin 3 A (BTN3A) isoforms are critical act...

全面介绍

书目详细资料

Principais autores:	Audrey Benyamine, Céline Loncle, Etienne Foucher, Juan-Luis Blazquez, Céline Castanier, Anne-Sophie Chrétien, Mauro Modesti, Véronique Secq, Salem Chouaib, Meritxell Gironella, Elena Vila-Navarro, Giuseppe Montalto, Jean-Charles Dagorn, Nelson Dusetti, Juan Iovanna, Daniel Olive
格式:	Artigo
语言:	Inglês
出版:	Taylor & Francis Group 2018-01-01
丛编:	OncoImmunology
主题:	immunotherapy butyrophilin 3 a btn3a cd277 pancreatic ductal adenocarcinoma
在线阅读:	http://dx.doi.org/10.1080/2162402X.2017.1372080
标签:	添加标签 没有标签, 成为第一个标记此记录!